The FDA has extended its approval of UCB’s BIMZELX to three new indications, extending the use of the drug to a total of four ...

David Carbone, Director of the James Thoracic Oncology Center and Professor of Internal Medicine at The Ohio State University ...

The series B fundraising will support the clinical development of next-generation multivalent vaccines against respiratory ...

UCB and Biogen revealed that their Phase 3 study testing dapirolizumab pegol in people with systemic lupus erythematosus met ...

Although vaccines already exist to prevent mpox, high prices and the risk of side effects make it difficult to roll them out ...

The original concerns of the US regulatory agency over the manufacturing of Eli Lilly’s Ebglyss seem to have been resolved, ...

Dandelion Health used its new clinical AI marketplace to analyze real-world data, showing that GLP-1 drugs may help prevent ...

The FDA has granted Orphan Drug and Rare Pediatric Disease Designations to Somite’s cell replacement therapy for the ...

The new company focuses on producing components needed to manufacture RNA-based therapies for which there is increasing ...

Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.

Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...

MinervaX and Wacker Biotech announced yesterday that they have entered into a manufacturing agreement for MinervaX’s ...